Enter an email address below to share the provider's page with someone you know.
Dr. John Bradley Allen is an ophthalmologist who
specializes in vitreoretinal diseases and surgery. He received two bachelor’s
degrees in biology and psychology from the University of Georgia, where he
graduated with highest honors. While earning his medical degree at the Medical
College of Georgia, he was a teaching assistant, anatomy tutor, dean’s research
fellow, and president of the Alpha Omega Alpha honor society. He completed an
internship at the University of Tennessee at Chattanooga, where he served as
chief resident. He then completed an ophthalmology residency and vitreoretinal
surgery fellowship at The Ohio State University. During his training Dr. Allen
has lectured at multiple national meetings and has been an investigator in a
number of clinical trials and research projects.
Dr. Allen practices at our Mooresville (144 Fountain Place, Mooresville, NC) and Statesville (646 Hartness Road, Statesville, NC) offices. To make an appointment with him, call 704-295-3000. You can also request an appointment online or through myCEENTAchart.
UndergraduateUniversity of Georgia, 2007Bachelor of Science in Biology, Bachelor of Science in PsychologyFirst Honor Graduate, Honors Program Graduate
MedicalThe Medical College of Georgia, 2011
InternshipResident/Transitional year program, University of Tennessee at Chattanooga, 2012
ResidencyDepartment of Ophthalmology, The Ohio State University, Columbus, OH, 2016
FellowshipVitreoretinal surgery, The Ohio State University, Columbus, OH, 2017
American Academy of Ophthalmology, Member, 2012-2015
Ohio State University Resident Advisory Council, Member, 2013-2014
UT Chattanooga Transitional Year Program, Chief Resident, 2011-2012
UT Chattanooga Graduate Medical Education Committee. Member, 2011-2012
UT Chattanooga Transitional Year Education Committee. Member, 2011-2012
UT Chattanooga House Staff Committee. Member, 2011-2012
UT Chattanooga Transitional Year Domestic Violence Fundraiser, Chair, 2011-2012
Alpha Omega Alpha Honor Society, President of Georgia Alpha Chapter, 2010-2011
Medical College of Georgia Homeless Clinic, Volunteer, 2009
Athens, GA Bethel Tutoring Program, Volunteer Tutor, 2005-2006
International Service and Learning Medical Service Trip, Participant, 2006
Alternative Spring Break HIV Service Trip, Participant, 2006
Dr. Allen provides intravitreal injections for macular degeneration and
diabetic eye conditions.
Dr. Allen provides laser therapy for diabetic eye conditions.
Dr. Allen offers vitrectomy, retina surgery, macular hole repair, macular pucker repair, treatment for floaters, and participation in multiple clinical trials utilizing promising new treatments for retinal diseases.
Colquitt County Hospital Authority's Trustee Scholarship, 2010Medical College of Georgia Pathology Honor Society, 2009Medical College of Georgia Dean’s Summer Research Fellowship, 2008Medical College of Georgia Meritorious Scholarship, 2007-2010University of Georgia Charter Scholarship, 2003-2007Charlotte Magazine Top Doctors, 2023
Dr. Allen has given continuing education talks including:
"Intravitreal injections: Current options, uses, and
complications"Infection Uveitis of the Posterior Segment: Cases and Review""Central Serous Retinopathy: Pathology, Clinical Courses, and Current Treatment Options"
Dr. Allen is involved in clinical trials and is actively recruiting patients with:
Hoffman-La Roche:A Multiple-Center, Multiple-Dose and Regimen, Randomized, Active Comparator Controlled, Double-Masked, Parallel Group, 36 Week Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RG7716 Administered Intravitreally in Patients With Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AVENUE)
Ophthotech corporation:A Phase 3 Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista® (Anti PDGF-B Pegylated Aptamer) Administered in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy in Subjects With Subfoveal Neovascular Age-related Macular Degeneration.
Allergan:Safety and Efficacy of Abicipar Pegol (AGN-150998) in Patients With Neovascular Age-related Macular Degeneration (SEQUOIA)
Hoffman-La Roche:A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration (SPECTRI)
Regeneron Pharmaceuticals:A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients With Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (PANORAMA)
Hoffman-La Roche:A multiple center, multiple dose, randomized active comparator controlled, double-masked, parallel group, 24-week study to investigate the safety, tolerability, pharmacokinetics, and efficacy of RO6867461 administered intravitreally in patients with diabetic macular edema (BOULEVARD)
Cebulla, Colleen & Stevenson, William & Law, Heather & Heisler-Taylor, Tyler & Hamadmad, Sumaya & Shah, Mohd & Kim, Bongsu & Davidorf, Frederick & Ohr, Matthew & Wells, Michael & Yanoga, Fatoumata & Chang, Susie & Terrell, William & Miller, Daniel & Klisovic, Dino & Allen, John & Shah, Niraj & Geraymovich, Elena & Tarabishy, Ahmad & Abdel-Rahman, Mohamed. (2019). MIF promoter polymorphisms are associated with epiretinal membrane but not retinal detachment with PVR in an american population. Experimental Eye Research. 185. 10.1016/j.exer.2019.05.007.
Ganapathy PS, Dun Y, Ha Y, Duplantier J, Allen JB, Farooq A, Bozard BR, Smith SB. Sensitivity of staurosporine-induced differentiated RGC-5 cells to homocysteine. Current Eye Research. 2010 Jan;35(1):80-90.
Allen, JB, and Ohr, M. Bartonella henselae presenting as a bilateral retinochoroiditis: Clinical and imaging features, diagnosis, and natural course. Accepted for oral presentation at American Society of Retina Specialists annual meeting, San Francisco, CA, August 10, 2016.
Allen, JB, Fleming, GP, and Cebulla, C. Coats' disease-associated vasoproliferative tumor of the retina with epiretinal membrane, uveitis, and uncontrolled glaucoma. Accepted for case conference at Retina Society annual meeting, San Diego, CA. September 14, 2016.
Allen, JB and Rogers, DL. Effects of the implementation of EMR in a private pediatric ophthalmology practice: Initial results. Presented at Ohio State Resident Research Day. June , 2015.
Allen, JB, Czyz, CN, and Cahill, KV. Retrospective analysis of temporal artery biopsies and patient reported complications. Presented at Ohio State Resident Research Day. June 14, 2013.
Allen, JB. I remember I drove for 18 hours but what is wrong with me now? Presented at the Southern Society of General Internal Medicine Conference, Feb. 10, 2012. New Orleans, LA.
Allen, B. Examining the protective effects of Deprenyl on neural retinal cells in a mouse model of diabetes. Department: Anatomy/Cell Biology, Medical College of Georgia, Augusta, GA (May 2008 – July 2008). Presented at the Dean’s Summer Research Fair August, 2008.
Allen, B. and Mandawat, A. Expression and renaturation of recombinant HL-1, a lectin-like protein that may function as a type II diabetes therapeutic. Presented at the UGA Center for Undergraduate Research Opportunities Symposium. April 9, 2007.
Multiple Grand Rounds presentations and eye exam teaching presentations to medical students and primary care residents.
Bollinger, K and Allen, JB. Isolation and quantification of the transgelin-2 protein in the glaucomatous and non-glaucomatous human eye. Medical college of Georgia. 2010.